Veklury

Chemical Nameremdesivir
Dosage FormInjection (intravenous; 100 mg/20 mL)
Drug ClassAntivirals
SystemRespiratory
CompanyGilead Sciences Inc.
Approval Year2020

Indication

  • To treat hospitalized adults and pediatric COVID-19 patients (12 years of age and older and weighing at least 40 kg).
Last updated on 12/18/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Veklury (remdesivir) Prescribing Information.2020Gilead Sciences Inc., Foster City, CA
Document TitleYearSource
Veklury: assessment report.2020European Medicines Agency